# Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Source: https://onco.cc/trials/nct03290534/  
OnCo record `nct03290534` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of CivaSheet in advanced solid tumours, run by CivaTech Oncology, now recruiting.

## Summary

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® is a phase 2 interventional study registered as NCT03290534 by CivaTech Oncology, with 40 participants planned, started 2019-03-13 and due to reach its primary completion in 2026-12. Interventions recorded: CivaSheet.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03290534
- Phase: 2
- Setting: Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
- Sponsor: CivaTech Oncology
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT03290534: https://clinicaltrials.gov/study/NCT03290534

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- companies: [CivaTech Oncology](https://onco.cc/companies/civatech-oncology/)

---
JSON: https://onco.cc/api/v1/entities/nct03290534.json